Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Receivables - Other: 2023

Historic Receivables - Other for Immunome (IMNM) over the last 1 years, with Dec 2023 value amounting to $289,000.

  • Immunome's Receivables - Other was N/A to $289,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $289,000, marking a year-over-year change of. This contributed to the annual value of $289,000 for FY2023, which is N/A change from last year.
  • According to the latest figures from Q4 2023, Immunome's Receivables - Other is $289,000, which was up 38.94% from $208,000 recorded in Q2 2023.
  • Immunome's Receivables - Other's 5-year high stood at $821,000 during Q1 2023, with a 5-year trough of $208,000 in Q2 2023.
  • Over the past 1 years, Immunome's median Receivables - Other value was $289,000 (recorded in 2023), while the average stood at $439,333.